Medical cannabis company CS Medica, through its subsidiary Cannordic, has signed a white label partnership for launch in Italy.

The first order, worth DKK 1,1 million, includes Pain & Arthritis Gel and Wound Gel with launch planned for the second quarter of 2025.

The company is in discussions to expand the range and global distribution to over 50 countries in the future.